Structural modifications to tetrahydropyridine-3-carboxylate esters en route to the discovery of M5-preferring muscarinic receptor orthosteric antagonists.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2013-02-18

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/jm301774uPMID 23379472PMCID PMC3676450
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure and Dynamics of the M3 Muscarinic Acetylcholine Receptor

  2012cited by this paper
• Microscopic binding of M5 muscarinic acetylcholine receptor with antagonists by homology modeling, molecular docking, and molecular dynamics simulation.

  2012cited by this paper
• Structure of the M3 Muscarinic Acetylcholine Receptor

  2012cited by this paper
• Chemical lead optimization of a pan G(q) mAChR M(1), M(3), M(5) positive allosteric modulator (PAM) lead. Part I: Development of the first highly selective M(5) PAM.

  2010cited by this paper
• Muscarinic receptor blockade in the ventral tegmental area attenuates cocaine enhancement of laterodorsal tegmentum stimulation‐evoked accumbens dopamine efflux in the mouse

  2010cited by this paper
• In Vitro Isolated Tissue Functional Muscarinic Receptor Assays

  2010cited by this paper
• Heterobiaryl and heterobiaryl ether derived M5 positive allosteric modulators.

  2010cited by this paper
• Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins.

  2009cited by this paper
• The M5 muscarinic receptor as possible target for treatment of drug abuse

  2009cited by this paper
• Efficient synthesis of trifluoromethyl and related trisubstituted alkene dipeptide isosteres by palladium-catalyzed carbonylation of amino acid derived allylic carbonates.

  2008cited by this paper
• Morphine-induced place preference: involvement of cholinergic receptors of the ventral tegmental area.

  2007cited by this paper
• Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development

  2007cited by this paper
• The Social Occupational Functioning Scale (SOFS): a brief measure of functional status in persons with schizophrenia.

  2006cited by this paper
• Identification of a novel 4-aminomethylpiperidine class of M3 muscarinic receptor antagonists and structural insight into their M3 selectivity.

  2006cited by this paper
• Synthesis and antimuscarinic properties of quinuclidin-3-yl 1,2,3,4-tetrahydroisoquinoline-2-carboxylate derivatives as novel muscarinic receptor antagonists.

  2005cited by this paper
• Midbrain muscarinic receptor mechanisms underlying regulation of mesoaccumbens and nigrostriatal dopaminergic transmission in the rat

  2005cited by this paper
• Reduced Cocaine Self-Administration in Muscarinic M5 Acetylcholine Receptor-Deficient Mice

  2005cited by this paper
• Enzyme-catalyzed kinetic resolution of piperidine hydroxy esters

  2004cited by this paper
• Muscarinic acetylcholine receptor antagonist

  2004cited by this paper
• Muscarinic acetylcholine receptor knockout mice: novel phenotypes and clinical implications.

  2004cited by this paper
• Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice

  2003cited by this paper
• Drug addiction.

  2003cited by this paper
• Novel insights into M5 muscarinic acetylcholine receptor function by the use of gene targeting technology.

  2003cited by this paper
• M1-M5 muscarinic receptor knockout mice as novel tools to study the physiological roles of the muscarinic cholinergic system.

  2003cited by this paper
• Synthesis and pharmacology of benzoxazines as highly selective antagonists at M(4) muscarinic receptors.

  2002cited by this paper
• Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia

  2002cited by this paper
• Multiple Muscarinic Acetylcholine Receptor Subtypes Modulate Striatal Dopamine Release, as Studied with M1–M5 Muscarinic Receptor Knock-Out Mice

  2002cited by this paper
• Synthesis and structure-activity relationships of M(2)-selective muscarinic receptor ligands in the 1-[4-(4-arylsulfonyl)-phenylmethyl]-4-(4-piperidinyl)-piperazine family.

  2002cited by this paper
• Improving the oral efficacy of CNS drug candidates: discovery of highly orally efficacious piperidinyl piperidine M2 muscarinic receptor antagonists.

  2002cited by this paper
• Synthesis and pharmacology of benzoxazines as highly selective antagonists at M4 muscarinic receptors

  2002cited by this paper
• Design and pharmacology of quinuclidine derivatives as M2-selective muscarinic receptor ligands.

  2001cited by this paper
• Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice

  2001cited by this paper
• Cholinergic dilation of cerebral blood vessels is abolished in M5 muscarinic acetylcholine receptor knockout mice

  2001cited by this paper
• Brain-Stimulation Reward Thresholds Raised by an Antisense Oligonucleotide for the M5 Muscarinic Receptor Infused near Dopamine Cells

  2000cited by this paper
• Characterization of the muscarinic receptor in isolated uterus of sham operated and ovariectomized rats

  1999cited by this paper
• Identification and characterization of m1 selective muscarinic receptor antagonists1.

  1999cited by this paper
• Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function

  1998cited by this paper
• Pharmacological characterization of muscarinic receptors in rabbit isolated iris sphincter muscle and urinary bladder smooth muscle

  1998cited by this paper
• The relevance of resting tension to responsiveness and inherent tone of human bronchial smooth muscle

  1998cited by this paper
• International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors.

  1998cited by this paper
• The M5 (m5) receptor subtype: fact or fiction?

  1997cited by this paper
• The neurobiology of drug addiction.

  1997cited by this paper
• Mutational Analysis of the Relative Orientation of Transmembrane Helices I and VII in G Protein-coupled Receptors (*)

  1995cited by this paper
• Muscarinic receptors--characterization, coupling and function.

  1993cited by this paper
• Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain.

  1993cited by this paper
• Localization of m5 muscarinic receptor mRNA in rat brain examined by in situ hybridization histochemistry.

  1990cited by this paper
• Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes.

  1988cited by this paper
• The Functional Output of the Mesolimbic Dopamine System

  1988cited by this paper
• Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.

  1988cited by this paper
• Robust modulation of [3H]dopamine release from rat striatal slices by D-2 dopamine receptors.

  1986cited by this paper
• Pathways of dopamine metabolism in the rabbit caudate nucleus in vitro

  1981cited by this paper
• Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

  1973cited by this paper

• meso-2,3-dibromosuccinic acid as a temperature-dependent catalyst for the selective synthesis of syn and anti-highly functionalized tetrahydropyridines: experimental and theoretical study

  2026cites this paper
• Synthesis of Functionalized 1,2,3,4-Tetrahydropyridines by the Reaction of 3-[(Propan-2-ylsulfanyl)methyl]pentane-2,4-dione with Anilines

  2025cites this paper
• Development of VU6036864: A Triazolopyridine-Based High-Quality Antagonist Tool Compound of the M5 Muscarinic Acetylcholine Receptor

  2024cites this paper
• Discovery of a potent M5 antagonist with improved clearance profile. Part 2: pyrrolidine amide-based antagonists.

  2022cites this paper
• Discovery of a potent M5 antagonist with improved clearance profile. Part 1: piperidine amide-based antagonists.

  2022cites this paper
• A Convenient Esterification of N ‐Heteroarene Methanols via C–CN Bond Cleavage of Benzoyl Cyanides as Acylating Sources

  2022cites this paper
• In Sılıco Screenıng for Neuroreceptor Targets and Derıvatızatıon of Alkaloıds from Phaeanthus Ophthalmıcus

  2022cites this paper
• Development of VU6019650: A Potent, Highly Selective, and Systemically Active Orthosteric Antagonist of the M5 Muscarinic Acetylcholine Receptor for the Treatment of Opioid Use Disorder.

  2022cites this paper
• Update on PET Tracer Development for Muscarinic Acetylcholine Receptors

  2021cites this paper
• Lemon juice mediated efficient and eco-friendly organic transformations

  2020cites this paper
• TAPSO** : A Highly Efficient and Ecofriendly Catalyst for the Synthesis ofα‐Aminophosphonates and Tetrahydropyridines **3‐[N‐Tris(hydroxymethyl)methylamino]‐2‐hydroxypropanesulfonic acid

  2020cites this paper
• Pyridines and Their Benzo Derivatives: Reactivity of Reduced Compounds

  2020cites this paper
• Structure-Based Design and Synthesis of an Isozyme-Selective MTHFD2 Inhibitor with a Tricyclic Coumarin Scaffold.

  2019cites this paper
• Muscarinic agonist, (±)-quinuclidin-3-yl-(4-fluorophenethyl)(phenyl)carbamate: High affinity, but low subtype selectivity for human M1 - M5 muscarinic acetylcholine receptors.

  2019cites this paper
• Organocatalytic Enantioselective Synthesis of Tetrahydropyridines

  2018cites this paper
• The Muscarinic Acetylcholine Receptor M5: Therapeutic Implications and Allosteric Modulation.

  2018cites this paper
• Facile Diastereoselective Synthesis of Functionalized Tetrahydropyridines Using Fe3O4/SiO2/TiO2 Nanocomposites

  2018cites this paper
• Efficient and Eco‐Friendly One‐Pot Synthesis of Functionalized Furan‐2‐one, Pyrrol‐2‐one, and Tetrahydropyridine Using Lemon Juice as a Biodegradable Catalyst

  2018cites this paper
• C(sp3)-H dehydrogenation and C(sp2)-H alkoxy carbonylation of inactivated cyclic amines towards functionalized N-heterocycles.

  2017cites this paper
• Synthesis of Functionalized Pyridines via Cu(II)-Catalyzed One-Pot Cascade Reactions of Inactivated Saturated Ketones with Electron-Deficient Enamines.

  2017cites this paper
• Homology Modeling and Docking Evaluation of Human Muscarinic Acetylcholine Receptors

  2016cites this paper
• Reversal of cardiac vagal effects of physostigmine by adjunctive muscarinic blockade.

  2016cites this paper
• Recent developments in multicomponent synthesis of structurally diversified tetrahydropyridines

  2016cites this paper
• Synthesis of Tetrahydropyridines from Morita–Baylis–Hillman Acetates of α,β‐Unsaturated Aldehydes Via an Intramolecular 1,6‐Conjugate Addition

  2016cites this paper
• Synthesis of O- and N-alkylated products of 1,2,3,4-tetrahydrobenzo[c][2,7]naphthyrin-5(6H)-one.

  2015cites this paper
• One-pot synthesis of polysubstituted 1,2,3,4-tetrahydropyridines

  2015cites this paper
• Development of a Novel, Orthosteric M5 Antagonist Possessing a High Degree of Muscarinic Subtype Selectivity

  2015cites this paper
• Muscarinic acetylcholine receptor binding affinities of pethidine analogs.

  2015cites this paper
• Muscarinic Acetylcholine Receptor Activators

  2014cites this paper
• Base-catalyzed retro-Claisen condensation: a convenient esterification of alcohols via C–C bond cleavage of ketones to afford acylating sources

  2014cites this paper
• Discovery, Synthesis and Characterization of a Highly Muscarinic Acetylcholine Receptor (mAChR)‐Selective M5‐Orthosteric Antagonist, VU0488130 (ML381): A Novel Molecular Probe

  2014cites this paper